Moreover, tumor location and ages of PC patients showed significant relevance to the expression of METTL14 (Table 1), which indicated METTL14 was closely related with tumor progression and could be utilized as a prognostic marker in pancreatic cancer. Here, METTL14 is linked to pancreatic neoplasm.